Literature DB >> 8836834

A new method for continual quantitation of viable cells on endothelialized polyurethanes.

V V Nikolaychik1, M M Samet, P I Lelkes.   

Abstract

Many of the segmented polyurethanes currently used in cardiovascular prostheses undergo either modification of their surface structure or are lined with a confluent monolayer of endothelial cells to improve their hemocompatibility. During the establishment of an endothelial cell lining on these biopolymers it is necessary to continually monitor the number of viable cells that are covering the substrate. Yet, not all of the conventional cell enumeration techniques are suitable for assessing the growth of endothelial cells on polyurethanes. Methods, such as direct cell counting, dye uptake, or DNA or protein staining require either a transparent scaffold or lead to termination of the culturing process prior to measurement. In addition, some of the spectroscopic assays are often hampered by interaction of the dyes and/or solubilizers with the various constituents (e.g., catalyzers, antioxidants) and/or functional groups in the polyurethane formulations. In addressing these problems, we adapted a novel, highly reproducible fluorescent assay which is based on reduction by viable cells of an electrochemically sensitive compound, Alamar Blue. The bioreduced product is soluble and stable in culture media and noncytotoxic. In addition, the assay is independent of the geometry or physicochemical properties of the polymeric surfaces. In the present study we focus on the implementation of this assay to monitoring attachment and growth of various endothelial cell types on segmented polyurethanes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836834     DOI: 10.1163/156856296x00057

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  7 in total

1.  Quantitative assessment of neuronal differentiation in three-dimensional collagen gels using enhanced green fluorescence protein expressing PC12 pheochromocytoma cells.

Authors:  Hadar Arien-Zakay; Shimon Lecht; Anat Perets; Blair Roszell; Peter I Lelkes; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2008-07-16       Impact factor: 3.444

2.  Biomimetic design and fabrication of porous chitosan–gelatin liver scaffolds with hierarchical channel network.

Authors:  Haibo Gong; Jephte Agustin; David Wootton; Jack G Zhou
Journal:  J Mater Sci Mater Med       Date:  2014-01       Impact factor: 3.896

3.  Enhanced survival and neurite network formation of human umbilical cord blood neuronal progenitors in three-dimensional collagen constructs.

Authors:  Marian M Bercu; Hadar Arien-Zakay; Dana Stoler; Shimon Lecht; Peter I Lelkes; Simcha Samuel; Reuven Or; Arnon Nagler; Philip Lazarovici; Uriel Elchalal
Journal:  J Mol Neurosci       Date:  2012-12-12       Impact factor: 3.444

4.  Angioneural crosstalk in scaffolds with oriented microchannels for regenerative spinal cord injury repair.

Authors:  Aybike Saglam; Anat Perets; Adam Charles Canver; Ho-Lung Li; Katherine Kollins; Gadi Cohen; Itzhak Fischer; Philip Lazarovici; Peter I Lelkes
Journal:  J Mol Neurosci       Date:  2012-08-10       Impact factor: 3.444

5.  GTSF-2: a new, versatile cell culture medium for diverse normal and transformed mammalian cells.

Authors:  P I Lelkes; E Ramos; V V Nikolaychik; D M Wankowski; B R Unsworth; T J Goodwin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

6.  Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1 (Nrg1).

Authors:  Mona Freidin; Samantha Asche; Thaddeus A Bargiello; Michael V L Bennett; Charles K Abrams
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

7.  Identification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus.

Authors:  Sheng-Hao Chao; John R Walker; Sumit K Chanda; Nathanael S Gray; Jeremy S Caldwell
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.